<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02792010</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL14_0235</org_study_id>
    <nct_id>NCT02792010</nct_id>
  </id_info>
  <brief_title>Feasibility and Reproducibility of T1 Rho MRI in the Evaluation of Hip Cartilage</brief_title>
  <acronym>CARHAT02</acronym>
  <official_title>Feasibility and Reproducibility of T1 Rho MRI in the Evaluation of Hip Cartilage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hip osteoarthritis is a frequent and invalidating disease. Early detection of cartilage
      modifications could provide better patient treatment. The T1rho MRI sequence allows the
      quantification of the cartilage signal that is correlated to modifications of the cartilage
      matrix, notably of the proteoglycans. The primary objective is to evaluate normal values of
      hip cartilage in vivo using T1rho MRI in healthy subjects and the reproducibility of the
      measurements. T1rho and T2 mapping sequences were acquired twice during the same session with
      30 minutes interval to see if values were modified after a 30 minutes delay in a supine
      position. The secondary objective was to assess the correlation between T1rho and T2 values.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quantification of the cartilage signal at T1rho MRI</measure>
    <time_frame>Up to one month after inclusion (Visit 1)</time_frame>
    <description>T1rho values of total hip cartilage and for each sub-region (mean, standard deviation, histogram)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantification of the cartilage signal at T1rho MRI</measure>
    <time_frame>15 (+/- 7) days after visit 1 (Visit 2)</time_frame>
    <description>T1rho values of total hip cartilage and for each sub-region (mean, standard deviation, histogram)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantification of the cartilage signal at T2 MRI</measure>
    <time_frame>Up to one month after inclusion (Visit 1)</time_frame>
    <description>T2 values of total hip cartilage and for each sub-region (mean, standard deviation, histogram)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantification of the cartilage signal at T2 MRI</measure>
    <time_frame>15 (+/- 7) days after visit 1 (Visit 2)</time_frame>
    <description>T2 values of total hip cartilage and for each sub-region (mean, standard deviation, histogram)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of cartilage lesions</measure>
    <time_frame>Up to one month after inclusion (Visit 1)</time_frame>
    <description>Morphological sequence to determine focal lesions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of cartilage lesions</measure>
    <time_frame>15 (+/- 7) days after visit 1 (Visit 2)</time_frame>
    <description>Morphological sequence to determine focal lesions</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>T1rho MRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients included had hip cartilage MRI with acquisition of T1rho MRI sequence.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hip cartilage MRI</intervention_name>
    <description>Hip cartilage MRI</description>
    <arm_group_label>T1rho MRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &lt;30

          -  Accepting to participate in the study and signed the written informed consent

          -  Covered by a health insurance system

        Exclusion Criteria:

          -  Pregnant woman or risk of pregnancy

          -  MRI contraindication

          -  Protected adults

          -  Language barrier

          -  Previous or current hip pain
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Baptiste PIALAT, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospices Civils de Lyon - HÃ´pital Edouard Herriot Pavillon B Radiologie</name>
      <address>
        <city>Lyon</city>
        <zip>69437</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2016</study_first_submitted>
  <study_first_submitted_qc>June 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 7, 2016</study_first_posted>
  <last_update_submitted>January 11, 2017</last_update_submitted>
  <last_update_submitted_qc>January 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>T1rho MRI</keyword>
  <keyword>hip</keyword>
  <keyword>cartilage</keyword>
  <keyword>Healthy participants</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

